Marshall Wace’s Denali Therapeutics DNLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$19.7M Sell
1,405,250
-783,172
-36% -$11M 0.02% 534
2025
Q1
$29.8M Buy
2,188,422
+399,685
+22% +$5.44M 0.04% 374
2024
Q4
$36.5M Sell
1,788,737
-178,404
-9% -$3.64M 0.04% 335
2024
Q3
$57.3M Sell
1,967,141
-451,692
-19% -$13.2M 0.07% 228
2024
Q2
$56.2M Buy
2,418,833
+272,454
+13% +$6.33M 0.08% 227
2024
Q1
$44M Buy
2,146,379
+478,982
+29% +$9.83M 0.07% 254
2023
Q4
$35.8M Buy
+1,667,397
New +$35.8M 0.06% 272
2023
Q2
Sell
-350,539
Closed -$8.08M 2110
2023
Q1
$8.08M Sell
350,539
-610,100
-64% -$14.1M 0.02% 677
2022
Q4
$26.7M Buy
960,639
+284,769
+42% +$7.92M 0.06% 317
2022
Q3
$20.7M Sell
675,870
-141,780
-17% -$4.35M 0.05% 402
2022
Q2
$24.1M Buy
817,650
+664,795
+435% +$19.6M 0.05% 351
2022
Q1
$4.92M Sell
152,855
-231,089
-60% -$7.44M 0.01% 1231
2021
Q4
$17.1M Sell
383,944
-147,414
-28% -$6.57M 0.03% 508
2021
Q3
$26.8M Sell
531,358
-114,641
-18% -$5.78M 0.11% 163
2021
Q2
$50.7M Buy
645,999
+546,481
+549% +$42.9M 0.23% 64
2021
Q1
$5.68M Buy
+99,518
New +$5.68M 0.03% 694
2020
Q4
Sell
-325,168
Closed -$11.7M 1796
2020
Q3
$11.7M Buy
325,168
+286,598
+743% +$10.3M 0.07% 233
2020
Q2
$933K Sell
38,570
-203,550
-84% -$4.92M 0.01% 988
2020
Q1
$4.24M Buy
242,120
+195,743
+422% +$3.43M 0.04% 420
2019
Q4
$808K Buy
+46,377
New +$808K 0.01% 992
2019
Q2
Sell
-15,473
Closed -$359K 1412
2019
Q1
$359K Buy
+15,473
New +$359K ﹤0.01% 1218